title: Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
abstract: Some of the issues associated with standardizing the diagnosis of dementia in clinical trials are outlined. Deliberations of the Working Group on Diagnostic Criteria and their recommendations for future actions needed to develop a consensus are described.
authors.affiliation: Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.
authors.forename: P
authors.initials: P
authors.lastname: Antuono
authors.forename: R
authors.initials: R
authors.lastname: Doody
authors.forename: S
authors.initials: S
authors.lastname: Gilman
authors.forename: J
authors.initials: J
authors.lastname: Huff
authors.forename: P
authors.initials: P
authors.lastname: Scheltens
authors.forename: K
authors.initials: K
authors.lastname: Ueda
authors.forename: Z S
authors.initials: ZS
authors.lastname: Khachaturian
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D002986:Clinical Trials as Topic; D003704:Dementia / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D015577:Geriatric Assessment / Q000706:statistics & numerical data; D006801:Humans; D007391:International Cooperation; D018697:Nootropic Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D012015:Reference Standards; D012307:Risk Factors
chemical_list: D018697:Nootropic Agents